Shelley Zhuang
Managing Partner at Cannage Capital
United States
Overview
Work Experience
Founder and Managing Partner
2024 - Current
Investor
2020
JupiterOne specializes in providing cybersecurity asset management solutions.
Raised $119,000,000.00 from Bain Capital Ventures, Cisco Investments, Tribe Capital, Sapphire Ventures, Splunk Ventures, Intel Capital and Alpha Square Group.
Seed Investor & Board Observer
2020
Sardine is fraud prevention and compliance software company for the digital economy.
Raised $75,600,000.00 from Visa, Andreessen Horowitz, Activant Capital, Nyca Partners, ING Ventures, ConsenSys, The General Partnership, XYZ Venture Capital, Eric Schmidt and Cross River Digital Ventures.
Seed Investor
2017
Covariant is an AI Robotics company developing a universal AI that enables robots to see, reason, and act on the world around them.
Raised $222,000,000.00 from CPP Investments, Radical Ventures, AIX Ventures, Northgate Capital, Gates Frontier Fund, Index Ventures, Amplify Partners, CPP Investments, Amplify Partners and Radical Ventures.
Seed Investor & Board Member, Observer
2016
Hinge Health is a digital clinic for joint, and muscle care, pelvic pain, bowel, and bladder control.
Raised $826,132,500.00 from Alkeon Capital and Whale Rock Capital Management.
Investor
2015
Forter is a software-as-a-service company that delivers real-time, automated, fraud prevention solutions for online merchants.
Raised $525,101,500.00 from Adage Capital Management, Sequoia Capital Israel, DFO Management, L Catterton, NewView Capital, Bessemer Venture Partners, Third Point Ventures, Tiger Global Management, Salesforce Ventures and Samsung NEXT.
Seed Investor
2014
Seed Investor
2014
HUMAN is a cybersecurity company that protects the internet and enterprises from fraud and sophisticated bot attacks.
Raised $200,593,068.00 from NightDragon, Vertex Ventures US, WestCap, ClearSky, Goldman Sachs Asset Management, Sigma Software Labs, WestCap, NightDragon, NightDragon and Grit Capital Partners.
Investor
2014
Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.
Raised $1,575,403,063.00 from Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention and Agriculture and Food Research Initiative.
Founder and Managing Partner
2013
11.2 Capital invests in founders solving the biggest challenges facing our world with emerging technologies. We focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology.